Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

NCT00467376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

485

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Insulin Glulisine
DRUG: Lispro
DRUG: Insulin Glargine

Sponsor

Sanofi